EZH2 and central nervous system cancer: Moreover, EZH2 regulates cell stemness and epithelial to mesenchymal transition (EMT) in gliomas [11], and it is involved in the development of multidrug resistance, with its inhibition restoring the normal drug sensitivity in GBM [13].